Evidence map›Paper›PMID 37068265›Full record

ArticleJournal of medicinal chemistry2023

High-Contrast PET Imaging with [

Nashaat Turkman, Sulan Xu, Chun-Han Huang, Christopher Eyermann, Julia Salino, Palwasha Khan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Can Nuclear Imaging Detect Trained Immunity in Cardiovascular Disease?Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Diagnostic and Therapeutic Radiopharmaceuticals: A "Hot" Topic.ACS pharmacology & translational science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nashaat TurkmanStony Brook Cancer Center, Stony Brook, Long Island, New York 11794, United States.ORCID 0000-0002-7943-6637
Sulan XuStony Brook Cancer Center, Stony Brook, Long Island, New York 11794, United States.
Chun-Han HuangStony Brook Cancer Center, Stony Brook, Long Island, New York 11794, United States.
Christopher EyermannDepartment of Radiology, School of Medicine, Stony Brook University, Long Island, New York 11794, United States.
Julia SalinoStony Brook Cancer Center, Stony Brook, Long Island, New York 11794, United States.
Palwasha KhanStony Brook Cancer Center, Stony Brook, Long Island, New York 11794, United States.

Funding

Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNSR01AG067417 · NIA · STATE UNIVERSITY NEW YORK STONY BROOK · PI TURKMAN, NASHAAT · 2020 to 2023
$3.0M
NIA NIH HHS R01 AG067417
6 · The paper itself

Abstract

We utilized positron emission tomography (PET) imaging in vivo to map the spatiotemporal biodistribution/expression of class-IIa histone deacetylases (class-IIa HDACs) in the central nervous system (CNS). Herein we report an improved radiosynthesis of [

Indexed as

Histone DeacetylasesPositron-Emission TomographyBrainEpigenesis, GeneticFluorine RadioisotopesHistone Deacetylase InhibitorsTissue DistributionFluorine RadioisotopesHistone Deacetylase InhibitorsHistone Deacetylases

Identifiers

PMID37068265
PMCPMC10150721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.